News | March 12, 2024
AbCellera and Biogen collaborate on neurological antibody therapy
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities
Subscribe To Our Newsletter & Stay Updated
